Evidence map›Paper›PMID 40776987›Full record

ReviewNew microbes and new infections2025

Novel and repurposed antiviral molecules for arbovirus infections with epidemic Potential: A systematic review.

Jacopo Logiudice, Giorgio Tiecco, Alessandro Pavesi, Francesca Bertoni, Roberta Gerami, Isabella Zanella, Anna Artese, SPARROW group, Eugenia Quiros-Roldan

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in New microbes and new infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jacopo LogiudiceASST Spedali Civili di Brescia. SC Malattie Infettive, 25123 Brescia, Italy.
Giorgio TieccoASST Spedali Civili di Brescia. SC Malattie Infettive, 25123 Brescia, Italy.
Alessandro PavesiASST Spedali Civili di Brescia. SC Malattie Infettive, 25123 Brescia, Italy.
Francesca BertoniASST Spedali Civili di Brescia. SC Malattie Infettive, 25123 Brescia, Italy.
Roberta GeramiASST Spedali Civili di Brescia. SC Malattie Infettive, 25123 Brescia, Italy.
Isabella ZanellaDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
Anna ArteseDipartimento di Scienze della Salute, Università degli Studi "Magna Grecia" di Catanzaro, Campus "Salvatore Venuta", Catanzaro, Italy.
SPARROW group
Eugenia Quiros-RoldanASST Spedali Civili di Brescia. SC Malattie Infettive, 25123 Brescia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This systematic review investigates experimental and repurposed antiviral molecules for epidemic-potential arboviruses, including dengue (DENV), Zika (ZIKV), chikungunya (CHIKV), West Nile (WNV), and Usutu (USUV) viruses. Arboviral diseases pose a growing public health concern, exacerbated by climate change and increased global travel. Despite the absence of approved antiviral therapies for most arboviruses, numerous

Indexed as

Antiviral therapyAntiviral treatmentArbovirusArbovirusesDengueDENVWest nileWNV

Identifiers

PMID40776987
PMCPMC12329100

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.